Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Last week patent highlights (10-29-09):
1. Compositions of and methods of using sulfatases from flavobacterium heparinum
2. Protein having prolyl oligopeptidase activity, nucleic acid encoding same and method for producing and using same
3. Dry Composition for Oral Ingestion and Gel Composition Prepared Just Before Use for Oral Ingestion
4. Combination Therapeutic products and systems
5. FATTY ACID TRIGLYCERIDES FOR MAKING BIOCOMPATIBLE COATINGS
6. CASPASE-8 AND INFLAMMATION, INFECTION AND WOUND HEALING
7. Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
8. REPLIKIN PEPTIDES IN RAPID REPLICATION OF GLIOMA CELLS AND IN INFLUENZA EPIDEMICS
9. BIOMARKERS FOR GRAFT REJECTION - Methods are disclosed for diagnosing rejection in a transplanted subject monitoring rejection in a transplanted subject
10. THERAPEUTIC AGENT FOR PROSTATE CANCER - The present inventors investigated the antitumor effects of anti-IL-6 receptor antibodies against prostate
11. ANTI-VEGF MONOCLONAL ANTIBODY - novel monoclonal antibodies with a high binding affinity to all five isoforms of human VEGF
12. COMPOSITIONS AND METHODS FOR TREATING DIABETES
13. HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
14. RESPONSES TO IMMUNIZATIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH A CD20 ANTIBODY
15. ANTIBODIES TO ONCOSTATIN M RECEPTOR - The invention provides characterization of the disease and cancer-associated antigen, OSM-R
16. LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME
17. Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
18. Dual Specific Immunotoxin for Brain Tumor Therapy
19. Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues
20. CLN248 Antibody Compositions and Methods of Use
21. Compositions Comprising Receptor-Associated Protein (RAP) Variants Specific for LRP2 and Uses Thereof
22. Pancreatic Cancer Genes - the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia
23. Pancreatic Cancer Genes - the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia
24. ANTIGENIC POLYPEPTIDES - method for the identification of antigenic polypeptides typically opsonic antigens
25. Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor
26. METHOD OF DIAGNOSING AND TREATING GLIOMA
27. ANTITUMOR AGENT COMPRISING SULFONAMIDE-CONTAINING HETEROCYCLIC COMPOUND COMBINED WITH AN ANGIOGENESIS INHIBITOR
28. Stimulation of T Cells Against Self-Antigens Using CTLA-4 Blocking Agents
29. QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT
30. Catalytic antibodies and a method of producing same
31. Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders
32. ANTI-TNFalpha ANTIBODY - antibody that binds TNF
33. Proteins with Improved Solubility and Methods for Producing and Using Same
34. Method of Treatment and Prophylaxis of Diseases Related to Amyloid Deposition Using IGM
35. THERAPY - inhibiting chemotherapy induced upregulation of Cathepsin S on the surface of tumour cells
36. Constructs for delivery of therapeutic agents to neuronal cells
37. Method for Controlling Immunodominance - Methods for controlling immunodominance are described
38. METHOD FOR SCREENING PEPTIDES FOR USE IN IMMUNOTHERAPY
39. HER-2/NEU MULTI-PEPTIDE VACCINE - multi-peptide-multiepitop-vaccine against cancerous diseases associated with HER-2/neu oncogene, i
40. IMMUNOGENIC VACCINIA PEPTIDES AND METHODS OF USING SAME
41. T CELL EPITOPE PEPTIDES OF 6B11 OVARIAN CANCER ANTI-IDIOTYPIC ANTIBODY
42. METHODS AND COMPOUNDS FOR MITIGATING PATHOGENIC OUTBREAKS USING REPLIKIN COUNT CYCLES
43. PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS
44. Ophthalmic Composition Comprising Xanthan Gum and Glucose
45. VACCINES COMPRISING MULTIMERIC HSP60 PEPTIDE CARRIERS
46. Process for the production of monoclonal antibodies
47. Enhanced Antiviral Activity Against Foot and Mouth Disease
48. Saposin C-DOPS: A Novel Anti-Tumor Agent
49. COSMETIC COMPOSITIONS FOR IMPROVING THE PERFORMANCE OF TRANSFER-RESISTANT AND LONG-WEARING
50. Tanning compositions containing juice concentrate
51. Stabilization of cosmetic compositions - composition of matter is used as an ingredient in cosmetics comprising at least
52. COSMETIC COMPOSITION FOR CARE AND/OR TREATMENT AND/OR MAKEUP OF THE EMULSION TYPE STRUCTURED WITH SILICONE POLYMERS
53. USE OF TANNINS IN FILTERS - the use of a tanning agent in or on filters in particular natural or synthetic fibrous fabric or foams
54. Material Having Antibacterial and Antifungal Properties
55. METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS
56. Pest Control Agent - Disclosed are a pest control composition, a method of pest control, and a method for preparing a pest control composition
57. FORMULATION - product comprising microcapsules which themselves comprise a polymeric shell
58. MEDICAL DEVICES HAVING INORGANIC PARTICLE LAYERS
59. BIOACTIVE THERMOGELLING POLYMER SYSTEMS AND METHODS OF THEIR USE
60. COMPOSITE IMPLANTS FOR PROMOTING BONE REGENERATION AND AUGMENTATION AND METHODS FOR THEIR PREPARATION AND USE
61. COMPOSITE IMPLANTS FOR PROMOTING BONE REGENERATION AND AUGMENTATION AND METHODS FOR THEIR PREPARATION AND USE
62. COMPOSITE IMPLANTS FOR PROMOTING BONE REGENERATION AND AUGMENTATION AND METHODS FOR THEIR PREPARATION AND USE
63. ALLOGRAFT BONE COMPOSITION HAVING A GELATIN BINDER
64. ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery
65. MEDICAL DEVICES, POLYMERS, COMPOSITIONS, AND METHODS FOR DELIVERING A HALOACETATE
66. Drug Delivery System And Methods Of Use - Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the
67. Drug Delivery System And Methods Of Use - Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the
68. Chewable Bilayer Tablet Formulation - Disclosed herein is a tablet formulation of an objectionable tasting drug cetirizine or its pharmaceutically
69. METHODS AND COMPOSITIONS FOR TREATING ONCHOMYCOSIS
70. USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT
71. DUAL ACTION, INHALED FORMULATIONS PROVIDING BOTH AN IMMEDIATE AND SUSTAINED RELEASE PROFILE
72. TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS
73. Compositions for the encapsulation of natural product extracts in oil medium in hard gelatin capsules and a method of encapsulation
74. PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
75. Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin
76. Controlled Release Solid Preparation - solid preparation which comprises at least one active ingredient and at least one dissolution-controlling base
77. MODIFIED RELEASE COMPOSITION OF AT LEAST ONE FORM OF VENLAFAXINE
78. ORAL CONTRACEPTIVE DOSAGE FORMS AND METHODS OF MAKING SUCH DOSAGE FORMS
79. Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods
80. ENZYME MEDIATED DELIVERY SYSTEM - The present invention includes compositions methods and systems for the development of a novel delivery vehicle that
81. Therapeutic uses of biocompatible biogel compositions
82. Poly-alpha(1-4)glucopyranose-based matrices with hydrazide crosslinking
83. Aqueous formulations of imidoalkanepercarboxylic acids
84. PHARMACEUTICAL COMPOSITIONS COMPRISING ESZOPICLONE
85. Inhibition of Neovascularization by Cerium Oxide Nanoparticles
86. MASKING THE TASTE OF POWDERS - Taste-masked powders that can be inhaled or administered orally a simple method for the production thereof
87. Pharmaceutical formulations for dry powder inhalers
88. FLOWABLE COLLAGEN MATERIAL FOR DURAL CLOSURE
89. PROCESS OF PREPARING MICROSPHERES FOR SUSTAINED RELEASE HAVING IMPROVED DISPERSIBILITY AND SYRINGEABILITY
90. NOVEL THERAPEUTIC AGENT DERIVED FROM MARINE ORGANISM
91. Compositions and Methods For Preventing or Treating Chronic Renal Failure in Felines With Hyperthyroidism
92. THIOLATED CHITOSAN GEL - Bodily tissue and structures may be coated with a protective gel layer made from a two-part composition whose first part
93. Compositions and Methods for Inducing Hair Growth
94. COSMETIC COMPOSITION BASED ON POLYUNSATURATED FATTY ACIDS AND ITS USES
95. SUBSTITUTED DIHYDROPYRAZOLONES AND THEIR USE
96. COATING MATERIAL - It is an object of the present invention to provide a coating material for a biomedical material surface which can control cell
97. METHODS FOR CONTROLLING ANGIOGENESIS AND CELL PROLIFERATION
98. Foot-bath Agent of Chinese Herbal Medicine for Regulating Blood pressure and Improving Sleep Quality
99. Peripheral blood flow-improving composition
100. Formulation and method for relieving or preventing symptoms associated with uric acid crystals
previous page next page
Archives
09-04-08 07-02-09 10-16-08 05-28-09 12-25-08 10-01-09 09-11-08 07-09-09 02-26-09 08-13-0911-20-08 07-30-09 12-18-08 09-10-09 11-27-08 04-16-09 06-11-09 01-08-09 05-14-09 11-06-08
08-27-09 09-24-09 10-15-09 06-18-09 09-17-09 03-26-09 01-15-09 10-30-08 06-25-09 12-04-08
10-08-09 08-06-09 02-19-09 06-04-09 10-23-08 02-12-09 04-23-09 09-25-08 05-21-09 01-29-09
03-05-09 12-11-08 03-19-09 04-30-09 01-01-09 10-22-09 07-23-09 07-16-09 05-07-09 02-05-09
03-12-09 10-02-08 04-09-09 09-03-09 08-20-09 04-02-09 10-09-08 11-13-08 01-22-09 08-28-08
09-18-08 08-21-08